Cytokinetics, Incorporated (CYTK)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 03:16PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 6.28B |
| Enterprise Value | 6.42B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.57k |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.71k |
| Enterprise Value/EBITDA | -15.82 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.72 |
| 52-Week Change 3 | 53.72% |
| S&P500 52-Week Change 3 | 26.36% |
| 52 Week High 3 | 110.25 |
| 52 Week Low 3 | 25.98 |
| 50-Day Moving Average 3 | 66.75 |
| 200-Day Moving Average 3 | 53.30 |
Share Statistics
| Avg Vol (3 month) 3 | 1.93M |
| Avg Vol (10 day) 3 | 1.54M |
| Shares Outstanding 5 | 104.85M |
| Implied Shares Outstanding 6 | 104.85M |
| Float 8 | 104.18M |
| % Held by Insiders 1 | 0.55% |
| % Held by Institutions 1 | 115.01% |
| Shares Short (Apr 30, 2024) 4 | 13.67M |
| Short Ratio (Apr 30, 2024) 4 | 12.15 |
| Short % of Float (Apr 30, 2024) 4 | 21.39% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 13.07% |
| Shares Short (prior month Mar 28, 2024) 4 | 13.23M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:6 |
| Last Split Date 3 | Jun 25, 2013 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -15,117.96% |
Management Effectiveness
| Return on Assets (ttm) | -36.66% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 3.75M |
| Revenue Per Share (ttm) | 0.04 |
| Quarterly Revenue Growth (yoy) | -81.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -485.59M |
| Net Income Avi to Common (ttm) | -530.6M |
| Diluted EPS (ttm) | -5.40 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 618.96M |
| Total Cash Per Share (mrq) | 5.9 |
| Total Debt (mrq) | 754.92M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.19 |
| Book Value Per Share (mrq) | -3.78 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -421.55M |
| Levered Free Cash Flow (ttm) | -264.91M |
© 2024 Yahoo. All rights reserved.